ALBEMARLE CORP News
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
see moreALBEMARLE CORP Market News
5d
Albemarle Faces Timing Risks Despite Strong EBITDA
- Analysts split on Albemarle as downgrades cite timing mismatches between lithium pricing and earnings while bullish forecasts point to a potential $2.5B Energy Storage EBITDA in 2026. A CFO retirement and upcoming Q1 results increase near-term investor focus.
12d
ALB Rally: U.S. Stockpile Bill, Lithium Tailwinds!
Recent U.S. legislation proposals and policy shifts in China, together with Albemarle’s latest operating trends, have created concrete near‑term catalysts for ALB. This article explains how a $2.5B critical‑minerals stockpile proposal, Chinese VAT rebate reductions on batteries, and Albemarle’s Q4/FY2025 results intersect to affect earnings, pricing, and investor outlook.
19d
Albemarle Up 25% as Lithium Prices Jump; Q1 Near!!
Albemarle shares surged roughly 25% last week, hitting a 52-week high as lithium prices recovered and the company outlined productivity targets. With Q1 results due May 6, investors are focused on margin recovery, lithium pricing, and execution of $150M cost plans.
26d
ALB Surges: BofA Upgrade, Lithium Rally, Plant Cut
Albemarle (ALB) received a Bank of America upgrade after lithium prices climbed and energy-storage demand strengthened. A recent closure of the Kemerton refinery and executive filings underscore management’s cost discipline and positioning ahead of upcoming results.
06 Apr at 04:01
Albemarle Strengthens Balance Sheet Board Upgrades
Albemarle completed a $670M Ketjen stake sale, will redeem $650M of 2027 notes, and added two experienced directors — moves that improve liquidity, lower interest burden, and reinforce governance ahead of its lithium-focused strategy.
30 Mar at 04:02
Albemarle Upsizes Tender, Idles Kemerton Refinery.
Albemarle (ALB) expanded a cash tender offer to $650M, accelerated debt reduction with early settlements and premiums, idled Train 1 at the Kemerton lithium hydroxide refinery to cut costs, and extended credit agreement maturities — moves that strengthen liquidity and margin resilience.
23 Mar at 04:03
Albemarle Moves: Ketjen Sale, Board Adds, Upside!!
Albemarle (ALB) logged concrete corporate moves this week—board additions, a near-term divestiture of its Ketjen catalyst stake, and fresh analyst optimism—that together reshape near-term cash flow and investor expectations amid a cautious specialty chemicals sector.